Gainers
- Solid Biosciences SLDB stock moved upwards by 113.3% to $4.33 during Thursday's pre-market session. The market cap stands at $199.4 million.
- Enlivex Therapeutics ENLV stock surged 75.75% to $10.44. The market value of their outstanding shares is at $140.1 million.
- AMAG Pharmaceuticals AMAG shares surged 42.55% to $13.4. The market cap stands at $459.2 million.
- Jaguar Health JAGX shares rose 20.89% to $0.35. The market value of their outstanding shares is at $12.0 million.
- PDS Biotechnology PDSB stock rose 13.72% to $2.65. The market cap stands at $40.7 million.
- ProPhase Labs PRPH shares moved upwards by 12.71% to $3.9. The market cap stands at $45.2 million.
- Genetic Technologies GENE stock increased by 11.84% to $3.87. The market cap stands at $46.5 million.
- Provention Bio PRVB stock rose 10.83% to $14.22. The market value of their outstanding shares is at $681.4 million.
- Intec Pharma NTEC shares surged 9.71% to $0.27. The market cap stands at $18.6 million.
- Biofrontera BFRA shares rose 8.55% to $8.5. The market cap stands at $190.6 million.
Losers
- Zosano Pharma ZSAN shares declined by 53.34% to $0.76 during Thursday's pre-market session. The market value of their outstanding shares is at $41.0 million.
- Selecta Biosciences SELB shares decreased by 39.52% to $1.5. The market value of their outstanding shares is at $131.2 million.
- LogicBio Therapeutics LOGC stock fell 28.97% to $6.45. The market cap stands at $151.1 million.
- Soleno Therapeutics SLNO stock decreased by 13.95% to $2.16. The market cap stands at $96.5 million.
- Genfit GNFT shares declined by 9.78% to $4.8. The market cap stands at $186.4 million.
- Iterum Therapeutics ITRM stock declined by 9.53% to $0.95. The market value of their outstanding shares is at $14.1 million.
- Tyme Technologies TYME shares declined by 8.17% to $0.9. The market cap stands at $113.1 million.
- Allena Pharmaceuticals ALNA stock sank 5.41% to $1.4. The market value of their outstanding shares is at $45.0 million.
- Artelo Biosciences ARTL stock decreased by 5.3% to $0.94. The market value of their outstanding shares is at $3.2 million.
- CTI BioPharma CTIC shares declined by 5.12% to $2.04. The market cap stands at $150.3 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPenny StocksPre-Market OutlookMarketsMoversTrading Ideashealthcare stocksInformation TechnologySemiconductorsTop Gainers
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in